Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.45K Sell
884
-2,666
-75% -$22.1K ﹤0.01% 2751
2025
Q4
$37K Sell
3,550
-18
-0.5% -$181 ﹤0.01% 1818
2025
Q3
$32.1K Buy
3,568
+2,736
+329% +$24K ﹤0.01% 1881
2025
Q2
$10.8K Buy
832
+741
+814% +$11.1K ﹤0.01% 2321
2025
Q1
$2.3K Buy
91
+16
+21% +$475 ﹤0.01% 2838
2024
Q4
$2.58K Hold
75
﹤0.01% 2795
2024
Q3
$3.71K Hold
75
﹤0.01% 2656
2024
Q2
$4.51K Hold
75
﹤0.01% 2550
2024
Q1
$3.87K Hold
75
﹤0.01% 2617
2023
Q4
$3.02K Hold
75
﹤0.01% 2656
2023
Q3
$2.09K Buy
+75
New +$2.24K ﹤0.01% 2759

Other funds holding RXST

SignatureFD's RXST Position: Q1 2026 in Review

SignatureFD reduced its RxSight (RXST) stake by 75% in Q1 2026, selling an estimated $22.1K and leaving 884 shares worth $5.45K. The position accounts for ﹤0.01% of the portfolio, ranked #2751.

SignatureFD first reported a position in RXST in Q3 2023 and has held it in 11 quarters since. The position peaked at $37K in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • SignatureFD held 884 shares of RxSight worth $5.45K as of Q1 2026.
  • SignatureFD sold 2,666 RxSight shares in Q1 2026, an estimated $22.1K.
  • RxSight made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #2751 holding.
  • SignatureFD first reported a position in RxSight in Q3 2023 and has held it in 11 quarters since.
  • SignatureFD's RxSight position peaked at $37K in Q4 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.